PROP leaders Dr. Jane Ballantyne and Dr. Mark Sullivan recently released their book on the origins of opioid epidemic and the concept of the right to pain relief following their article published in The Clinical Journal of Pain in 2021. […]

In this cohort study, decreasing opioid dose was associated with reduced risk of opioid use disorder and continued opioid therapy but increased risk of disenrollment compared with stable dosing, whereas the high-dose increasing trajectory was associated with an increased risk […]

PROP recently presented at the United Nations Commission on Narcotic Drugs policy meeting in Vienna, Austria. The Commission on Narcotic Drugs (CND) was established by Economic and Social Council (ECOSOC) resolution 9(I) in 1946, to assist the ECOSOC in supervising the application […]

PROP members Mark Sullivan and Jane Ballantyne published this editorial in the American Journal of Psychiatry, rebutting and questioning the findings of Hasin et al. This article argues that the “opioid-adjusted” and “pain-adjusted” versions of the DSM-5 Opioid Use Disorder […]

In addition to untold years of productivity lost from fatal overdoses, the nation’s labor participation rate has shrunk steadily since 2000. Precise correlation is elusive, but any graph of that decline would stand in sharp contrast to the rise of […]

A Viewpoint article published in JAMA discusses the implications and takeaways from the recent CDC report on drug overdose deaths. the authors note that “Raising awareness about worsening disparities in overdose deaths among racial and ethnic minority populations and inequities […]